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THE EFFECT OF TOPICAL ANTIPRTJRITIC THERAPY ON
EXPERIMENTALLY INDUCED PRIJRITUS IN MAN*
FRANK M. MELTON, M.D. AND WALTER B. SHELLEY, M.D., Px.D.
A review of the literature on topical therapy discloses a vast numbe of
medicaments which have been acclaimed for their effectiveness as antipruritic
agents. The range is from hydrocyanic acid (1) to calamansi juice (2). Un-
fortunately, many of these reports are based on clinical impressions and are not
grounded on even simply controlled data. With the exception of certain of the
current studies on antihistaminic preparations (3, 4, 5, 6), neither placeboes nor
controlled comparisons on symmetrical bilateral areas (7) have found employ-
ment in these evaluations. Moreover, the medical literature abounds in reports
on these purportedly efficacious measures with little evidence of any refutation.
The recording of negative or conflicting data seems to have given way entirely
to the presentation of more recipes for the relief of itching.
Experimental data on methods of achieving topical antiprurisis are lacking,
and prior to current data on topical antihistaminic therapy, but one solitary
report was uncovered in which a controlled clinical study of a topical medicament
was undertaken. In this work (8), the effect of nupercaine was studied on hospital-
ized patients with various pruritic dermatoses. No antipruritic properties could
be demonstrated when applied to lesions of dermatitis herpetiformis, eczema, and
prurigo. It was found that the vehicle alone afforded the same degree of relief
from pruritus as did the nupercaine ointment. However, the nupercaine was
strikingly effective when used to combat pain in ulcerated or fissured areas.
The present investigation originated from a desire to have a more objective
body of data on the usefulness of antipruritic agents. Preliminary study on the
effect of an antipruritic ointment on clinical pruritus seen in an out-patient
dermatologic service made evident the disadvantages of such an approach.
Dependence upon a mixture of reliable and unreliable observations of patients
joined with continual and unavoidable spontaneous fluctuations in the intensity
of itching led to results of questionable significance. It was decided to turn to an
experimental approach since a short, definite, experimentally produced itch
could serve as a yardstick for rapid comparison of the effect of many compounds.
After a review of methods of experimentally induced pruritus (itch powder
tuning fork, electrical stimulation, and histamine) disclosed no satisfactory
standardized type of itch stimulus, a study was made of the histamine pruritus
with a view to standardization. It was found (9) that histamine could be intro-
duced into the skin and produce transitory itching by means of topically applied
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solutions, iontophoresis, subcutaneous or intradermal injection, and by pin
prick through solutions on the skin. Intradermal injection proved to be the
most suitable method for this study. Accordingly, a survey was made of the
effect of topical medication on well-defined histamine pruritus experimentally
produced in normal human skin.
METHOD
The effects of fifty-four topical antipruritic preparations were tested on experi-
mental localized pruritus in three normal adult male subjects. This pruritus was
induced on the flexor surface of the forearm or the anterior surface of the thigh
by the intracutaneous injection of 0.05 milliliter of 1/100,000histamine phos-
phate (concentration expressed as free base equivalent). The histamine solution
was always freshly prepared in a sterile, buffered, saline diluent.' The use of
distilled water or physiological saline solution proved to be unsatisfactory. The
pruritus produced was rated as moderate in intensity for ten to fifteen minutes
under control conditions and at times was faintly perceptible for as long as
thirty minutes. The appreciation of this pruritus required the attention of the
subject, which was achieved through periodic questioning. Room temperature
was kept as constant as possible, always being above 70°F., since a cold environ-
ment appreciably shortened the duration and intensity of the pruritus.
The compounds under observation were rubbed on the skin for one minute by
the investigator's forefinger. Each compound was applied over an area approxi-
mately two inches in diameter and two inches proximal to the preceding applica-
tion. A second application was not made to a site until after an interval of one
week, and applications were not made on any site in which there was evidence
of disturbance of the integrity of the skin. Only one compound was tested at a
time, as previous studies had shown that it was difficult to distinguish between
pruritic sensations arising from different areas. The compounds were used
randomly and neither the investigator nor subjects knew what was being used.
Two series of tests were conducted on each preparation. Control buffer diluent
injections were made similarly. In the first series, the compounds were rubbed on
the skin for one minute. Fifteen minutes later, pruritus was induced by the
injection of the histamine solution into the center of the treated area. The in-
tensity of the sensation was recorded each minute for five minutes.
In the second series, the histamine was injected into the skin first. Then
immediately upon the appearance of pruritus the compOund being tested was
rubbed into the area for one minute. Pruritus was thereupon graded and recorded
each minute for five minutes.
1 Buffered diluent: NaH,P04 0.576 cc.
Na,11P04 2.50 cc.
NaCI 8.50 cc.
Distilled 11,0 to 1000.00 cc.
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The following is a listing of the agents evaluated:
Group I (Single Component Preparations)
Benzocaine 5% Phenol 2%
Liquid petrolatum 15% Shake lotiont q.s.
Aquaphor q.s q.s.
Phenol 2%
Benzocaine 5% TJng. aqua rosae q.s.
Olive oil 5%
Water 20% Procaine base 1%
Aquaphor 70% Aquaphor q.s.
Benzocainc 5% Procaine base 15%
Oil/water base* q.s. Oleic acid q.s.
Benzyl alcohol 10% Procaine base 1%
Aquaphor (25% water) q.s. Oil/water base* q.s.
Benzyl alcohol 50% Procaine base 1%
Distilled water 25% Lanolin 30%
Ethyl alcohol 25% Petrolatum 50%
Water 19%
Camphor 1%
Penetrant vehicles q.s. Procaine base 1%
Penetrant vehicles q.s.
Camphor 2%
Shake lotionf q.s. Procaine base 1%
Penetrant vehicle q.s.Camphor 2%
Ung. aqua rosae q.s. Procaine HC1 1%
Aquaphor q.s.Menthol 1%
Shake lotiont q.s. Procaine HCI 1%
Oil/water base* q.s.Menthol 1%
Ung. aqua rosae q.s. Procaine HCl 1%
Lanolin 30%Nupercaine base 2.5% Petrolatum 50%Propylene glycol q.s. Water 19%
Nupercaine HC1 1% Pyribeuzamine HC1 6.5%Aquaphor q.s. Penetrant vehicles q.s.
Nupercaine HC1 1% Pyribenzamine HCl 2%Shake lotiont q.s. Inert filler 6%
Duponol 1%Oil of bitter almond 0.2% Saric acid 10%Distilled water q.s. Cetyl alcohol 5%
Glycerin 5%
Phenol 2% Phenylmercuric acetate 0.001%
Calamine lotion q.s. Water q.s.
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Pyribenzamine HC1
Inert filler
Lanolin
Petrolatum
TJrethane 30%
Penetrant vehicles q.s.
Yellow oxide of mercury 1%
Ung. aqua rosae q.s.
* Oil/water base:
Stearly alcohol 10 parts
Cetyl alcohol 3 parts
Spermaceti 10 parts
Glycerin 10 parts
Sodium lauryl sulfate 1 part
Distilled water 61 parts
t Shake lotion:
Zinc oxide 5%
Talc 5%
Glycerin 25%
Calcium hydroxide 20%
Olive oil 45%
Penetrant vehicle No. 1:
Aerosol 1.0%
Antipyrine 5.4%
Propylene glycol 56.0%
Distilled water q.s.
§ Penetrant vehicle No. 2 (Intraderm
tyrothricin base kindly supplied by Wallace
Laboratories)
Sodium mixed alkyl benzene
sulfonates 1%
Propylene glycol 10%
Distilled water q.s.
Group II (Multiple Component Preparations)
Calamine 8%
Zinc oxide 8%
Glycerin 2%
Solution calcium hydroxide q.s.
Liquor carbonis detergens 10%
Aqua calcis
Olive oil aa q.s.
Menthol 0.25%
Phenol 1.0%
Ichthammol 3.0%
Zinc oxide ointment q.s.
Menthol 0.25%
Liquor carbonis detergens 5.0%
Choral hydrate 2.9%
Calamine lotion q.s.
Menthol 0.5%
Calomel 5.0%
Benzocaine 5.0%
Zinc oxide 5.0%
Talc 5.0%
Glycerin 24.0%
Lime water 20.0%
Olive oil 35.5%
Menthol 0.25%
Phenol 1.0%
Liquor carbonis detergens 10.0%
Benzocaine 10.0%
Calamine lotion q.s.
Phenol 1.0%
Camphor 0.5%
Glycerine 1.0%
Liquor carbonis detergens 3.0%
Starch 5.0%
Cottonseed oil
Lime water aa q.s.
Menthol 0.25%
Phenol 0.5%
Crude coal tar 2.0%
Ammoniated mercury 3.0%
Zinc oxide ointment q.s.
Group III (Proprietary Preparations)
BAUME BENGUE (Leeming)
Menthol
Methyl salicylate
CALIGESIC (Sharp and Dohme)
Benzocaine
Hexylated metacresols
BENADRYL OINTMENT (Parke-Davis) CALMITOL (Leeming)
Benadryl Chlorocamphoric aldehyde
2%
6%
40%
q.s.
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Iodine Isopar
Menthol
ilyoscine oleate MAZON (Belmont)
Mercury salicylate
DERMAL PENATRIN (Zemmer) Benzoic acid
Resorcin Salicylic acid
Phenol Tars
Menthol
NUPERCAINAL (Ciba)
DERMOCAINE (Walker) Nupercaine
Bismuth subnitrate
Salicylic acid PANTHESIN (Sandoz)
Benzocaine Panthesin
ICHTHYMALL (Mallinckrodt) TARBONIS (Tarbonis)
Sulphonated shale oil Liquor carbonis detergens
INOTON (Fougera) TEN-TEN-E (Smith, Kline and French)
Hypersulphonated shale oil Menthol
Ichthyol Camphor
Extract of witch hazel Chiorothymol
ISOPAR (Medical) THIGENOL (Roche)
Cetyl alcohol Suipholeic acid
RESULTS
Under the conditions of this testing, not a single one of the fifty-four prepa-
rations evaluated had a consistent, definite effect on the histamine pruritus.
In no instance was the pruritus prevented from appearing. Furthermore, applica-
tion of the agents after the pruritus had been induced had no real effect on the
course of the itching. Partial suppression was seen occasionally in one or two
subjects, but, again, this was not significant since it could not be demonstrated
on repeat trials.
Fifteen control experiments were performed on each of the three subjects. In
these tests nothing was applied topically. In each instance the pruritus was
present for longer than five minutes.
The application of epinephrine base (0.1 per cent) in a penetrant vehicle
caused marked blanching of the area to which it was applied. No pruritus could
be induced in the areas so treated.
The pruritus could be abolished or prevented from appearing by the applica-
tion of ice water compresses to the area as well as by mechanically slapping the
area.
DISCUSSION
The need for unequivocal decisive evaluation of the role of antipruritic meas-
ures cannot be met conveniently by out-patient clinical studies. Accordingly, in
this study, topical antipruritic preparations were evaluated on an experimental
histamine pruritus in normal skin. This approach limits the clinical extension of
the data to pruritus, which is seen in such conditions as urticaria, seborrhea,
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miliaria, Fox-Fordyce disease, lichen planus, pityriasis rosea, mycosis fungoides,
and essential pruritus of peripheral origin. In no instance, can the data shed
light on the value of these agents in pruritus arising in skin showing abnormal
epidermal permeability.
The ineffectiveness of all fifty-four of the selected antipruritic preparations was
unexpected and led to a review of the factors concerned in the relief of itching.
Topical antipruritic agents are commonly assumed to afford nonspecific
protection against external pruritogenic stimuli. This function could not be
assayed in the present testing. However, the effects of topical antipruritic prepa-
rations upon the terminal nerve ending could be determined. The preparations
studied did not anesthetize the nerve endings, nor did they produce substitutive
sensations to the point of effectively combatting pruritus.
Certain factors may be suspected as the explanation of these findings. In the
first place, the skin barrier prevented sufficient quantities of active compound
frOm being absorbed. This is the critical factor, we feel, since intracutaneous
injections of many of the agents used rapidly and effectively abolished the
pruritus. The normal undamaged human epidermis is far less permeable to medica-
ments than is commonly appreciated. This pilosebaceous apparatus and the sweat
glands provide the only, and accordingly a very limited, entry for material. An
important exception to this is the fact that gases do pass directly through the
epidermis. On this basis, a volatile antipruritic or local anesthetic might be ex-
pected to be more effective than the solid or liquid agents with such a limited
portal of entry. Unfortunately, no gaseous agents were tested.
A second factor to be considered is that of time. The compounds were given
only five to fifteen minutes in which to act. In the first series, fifteen minutes
after the ointment was applied, the itch stimulus was given. This interval was
chosen because it was felt that within this time an absorption equilibrium might
be expected to have been established. However, cumulative toxic or other delayed
effects are missed by this technic. In this reference, Freystadtl's report (10)
should be mentioned since it would suggest that a long interval must elapse
before effects occur. Freystadtl challenged the statement that uninjured skin is
impermeable to local anesthetics. He found that the application of aqueous
solutions of nupercaine (10 per cent) or pontocaine (8 per cent) eliminated the
sensation of cold and reduced the sensation of pain. Touch was unaffected.
Cocaine (7 per cent) and novocaine (6 per cent) were not effective. However,
hours were required to achieve this effect. He also found that nupercaine base
(0.10), olive oil (1.0), and adeps lanae (q.s. ad 10.00) eliminated the sensations of
cold, pain, and touch after eighteen hours. No experimental studies were made
on pruritus, but he reported that this preparation was clinically effective against
pruritus. It is important to note that his effects are not seen until after a period
of hours. Phenol, on the other hand, in a 5 per cent aqueous solution or a 30 per
cent glycerin solution, eliminated the sensation of cold and touch in thirty
minutes with a reduction in pain perception. In contrast, 10 per cent menthol,
camphor, and thymol had no effect on the sensations studied.
It is of interest to note that Kasuga (11), in an abstract published in 1940,
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also found that anesthesia to touch was produced in 33 per cent phenol in lanolin
or by a nupercaine base preparation in water. Other preparations, as chloroform,
paraldehyde, and various alcohols, were ineffective. No details are given, and no
studies were made concerning pruritus.
Lastly, the preparations used in the present study were applied to a small area
about the point stimulately by histamine. This must be contrasted with the large
areas which may be treated clinically since it is possible that the application to
large fractions of the skin surface is more effective.
The ineffectiveness of the array of preparations applied in this study leads to
the question of how could the experimental histamine pruritus be prevented. It
was found that in an area in which pain had been produced by such measures as
slapping, pruritus did not appear. Moreover, pruritus would not arise in areas to
which ice cold compresses had been applied, possibly due to the competitive
stimulus or through vascular changes. Finally, the introduction of adrenalin into
the skin by means of iontophoresis, or topical application, in quantities sufficient
to produce complete local blanching, also inhibited the appearance of itching.
The results of this study afford no experimental confirmation of the effective-
ness of topical antipruritic therapy in the presence of skin with normal permea-
bility.
CONCLUSIONS
The effect of fifty-four topical antipruritic preparations was evaluated on
histamine pruritus experimentally produced in normal human skin. It was found
that none of the compounds had a significant or consistent effect on this histamine
pruritus, produced either one minute before or fifteen minutes after the anti-
pruritic was applied topically.
A survey of the factors responsible for this ineffectiveness indicates the im-
permeability of normal human skin to be of major importance.
It was concluded that this study provided no experimental evidence to indi-
cate usefulness of local antipruritic medicaments when applied to skin of normal
permeability.
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After submitting this manuscript for publication, an interesting experimental
evaluation of topical antipruritic agents was uncovered (Haas, H. T. A., tiber
den Juckreiz, Klin. Wschr., 24: 353, 1947). In this work, Haas applied the test
preparations to the normal skin of two to four subjects. One hour later, the effect
was graded on an experimental histamine pruritus (1/1000, in scratch). None of
the twenty-seven preparations studied consistently prevented the appearance
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of the histamine pruritus. This would agree with our findings recorded above.
However, Haas on the basis of comparative grading, which was not attempted
by us, did report that the following agents partially alleviated the pruritus:
formaldehyde (1 per cent aqueous), menthol (1 per cent in 50 per cent alcohol,
2 per cent in petrolatum or eucerin), nupercaine (5 per cent ointment), phenol
(2 per cent in water or petrolatum or eucerin), priscol (10 per cent ointment),
resorcin (2 per cent in water or petrolatum), and thymol (1 per cent in 50 per
cent alcohol or petrolatum).
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